Synektik S.A. Logo

Synektik S.A.

Provides medical tech for diagnostic imaging, nuclear medicine, and robotic surgery.

SNT | WAR

Overview

Corporate Details

ISIN(s):
PLSNKTK00019
LEI:
259400U0O19JWLVHQN14
Country:
Poland
Address:
WARSZAWA JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA

Description

Synektik S.A. is a medical technology company providing innovative products, services, and IT solutions for diagnostic imaging, nuclear medicine, and robotic surgery. The company is a leading manufacturer and supplier of radiopharmaceuticals used in oncological diagnostics, particularly for Positron Emission Tomography (PET). In addition to its pharmaceutical operations, Synektik develops specialized medical software, such as Picture Archiving and Communication Systems (PACS), and supplies advanced medical equipment, including the da Vinci robotic surgical systems. It offers comprehensive solutions and support for medical facilities, with a focus on the field of radiology.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 13:06
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.3 KB
2025-12-05 08:00
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.1 KB
2025-12-04 14:58
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.5 KB
2025-12-03 12:37
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.5 KB
2025-11-18 08:39
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 4 kw. 2024
Polish 1.3 MB
2025-11-18 08:39
wybrane dane finansowe za 4 kw. 2024
Polish 204.6 KB
2025-10-28 09:40
Terminy publikacji raportów okresowych - Content (PL)
Polish 2.0 KB
2025-10-27 15:29
Zawiadomienie
Polish 83.0 KB
2025-10-27 15:29
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie publicznej - zmiana …
Polish 1.7 KB
2025-10-27 12:52
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-23 12:37
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-21 08:51
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-20 10:43
Temat: Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - C…
Polish 1.8 KB
2025-10-14 14:39
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.3 KB
2025-10-09 09:16
Wybrane dane operacyjne segmentu sprzedaży sprzętu, rozwiązań IT oraz usług - C…
Polish 1.4 KB

Automate Your Workflow. Get a real-time feed of all Synektik S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Synektik S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Synektik S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Astria Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapies for allergic and immunologic diseases.
United States of America
ATXS
ATAI Life Sciences N.V. Logo
Develops psychedelic-inspired therapies for mental health disorders.
United States of America
ATAI
Atea Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing oral antiviral therapies for serious viral diseases.
United States of America
AVIR
Athira Pharma, Inc. Logo
Biopharma firm developing small molecule therapeutics for neurodegenerative diseases.
United States of America
ATHA
ATOSSA THERAPEUTICS, INC. Logo
Clinical-stage biopharmaceutical company developing oncology medicines for breast cancer.
United States of America
ATOS
aTYR PHARMA INC Logo
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
United States of America
ATYR
Aura Biosciences, Inc. Logo
Develops Virus-Like Drug Conjugates as targeted therapies for solid tumors.
United States of America
AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharmaceutical company developing therapies for severe autoimmune diseases.
United States of America
AUPH
AURORA CANNABIS INC Logo
Global producer and distributor of cannabis for medical and recreational markets.
United States of America
ACB
Autolus Therapeutics plc Logo
Biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases.
United States of America
AUTL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.